Home > Research > Publications & Outputs > Updating the probability of study success for c...

Links

Text available via DOI:

View graph of relations

Updating the probability of study success for combination therapies using related combination study data

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Updating the probability of study success for combination therapies using related combination study data. / Graham, Emily; Harbron, Chris; Jaki, Thomas.
In: Statistical Methods in Medical Research, Vol. 32, No. 4, 30.04.2023, p. 712-731.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Graham E, Harbron C, Jaki T. Updating the probability of study success for combination therapies using related combination study data. Statistical Methods in Medical Research. 2023 Apr 30;32(4):712-731. Epub 2023 Feb 12. doi: 10.1177/09622802231151218

Author

Graham, Emily ; Harbron, Chris ; Jaki, Thomas. / Updating the probability of study success for combination therapies using related combination study data. In: Statistical Methods in Medical Research. 2023 ; Vol. 32, No. 4. pp. 712-731.

Bibtex

@article{630cb8d352494fd08d01bac702a99b8b,
title = "Updating the probability of study success for combination therapies using related combination study data",
abstract = "Combination therapies are becoming increasingly used in a range of therapeutic areas such as oncology and infectious diseases, providing potential benefits such as minimising drug resistance and toxicity. Sets of combination studies may be related, for example, if they have at least one treatment in common and are used in the same indication. In this setting, value can be gained by sharing information between related combination studies. We present a framework that allows the study success probabilities of a set of related combination therapies to be updated based on the outcome of a single combination study. This allows us to incorporate both direct and indirect data on a combination therapy in the decision-making process for future studies. We also provide a robustification that accounts for the fact that the prior assumptions on the correlation structure of the set of combination therapies may be incorrect. We show how this framework can be used in practice and highlight the use of the study success probabilities in the planning of clinical studies.",
keywords = "Health Information Management, Statistics and Probability, Epidemiology",
author = "Emily Graham and Chris Harbron and Thomas Jaki",
year = "2023",
month = apr,
day = "30",
doi = "10.1177/09622802231151218",
language = "English",
volume = "32",
pages = "712--731",
journal = "Statistical Methods in Medical Research",
issn = "0962-2802",
publisher = "SAGE Publications Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Updating the probability of study success for combination therapies using related combination study data

AU - Graham, Emily

AU - Harbron, Chris

AU - Jaki, Thomas

PY - 2023/4/30

Y1 - 2023/4/30

N2 - Combination therapies are becoming increasingly used in a range of therapeutic areas such as oncology and infectious diseases, providing potential benefits such as minimising drug resistance and toxicity. Sets of combination studies may be related, for example, if they have at least one treatment in common and are used in the same indication. In this setting, value can be gained by sharing information between related combination studies. We present a framework that allows the study success probabilities of a set of related combination therapies to be updated based on the outcome of a single combination study. This allows us to incorporate both direct and indirect data on a combination therapy in the decision-making process for future studies. We also provide a robustification that accounts for the fact that the prior assumptions on the correlation structure of the set of combination therapies may be incorrect. We show how this framework can be used in practice and highlight the use of the study success probabilities in the planning of clinical studies.

AB - Combination therapies are becoming increasingly used in a range of therapeutic areas such as oncology and infectious diseases, providing potential benefits such as minimising drug resistance and toxicity. Sets of combination studies may be related, for example, if they have at least one treatment in common and are used in the same indication. In this setting, value can be gained by sharing information between related combination studies. We present a framework that allows the study success probabilities of a set of related combination therapies to be updated based on the outcome of a single combination study. This allows us to incorporate both direct and indirect data on a combination therapy in the decision-making process for future studies. We also provide a robustification that accounts for the fact that the prior assumptions on the correlation structure of the set of combination therapies may be incorrect. We show how this framework can be used in practice and highlight the use of the study success probabilities in the planning of clinical studies.

KW - Health Information Management

KW - Statistics and Probability

KW - Epidemiology

U2 - 10.1177/09622802231151218

DO - 10.1177/09622802231151218

M3 - Journal article

VL - 32

SP - 712

EP - 731

JO - Statistical Methods in Medical Research

JF - Statistical Methods in Medical Research

SN - 0962-2802

IS - 4

ER -